Sowell Financial Services LLC Ngm Biopharmaceuticals Inc Transaction History

Sowell Financial Services LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 07, 2021	SELL	$24.99 - $31.93 $9,596 - $12,261	-384 Closed	0 $0
Q4 2020 Jan 13, 2021	BUY	$16.21 - $31.44 $4,344 - $8,425	268 Added 231.03%	384 $12,000
Q3 2020 Nov 12, 2020	BUY	$15.59 - $19.97 $1,808 - $2,316	116 New	116 $2,000
Q2 2020 Aug 13, 2020	SELL	$11.97 - $23.47 $22,551 - $44,217	-1,884 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$10.0 - $19.51 $14,080 - $27,470	-1,408 Reduced 42.77%	1,884 $24,000
Q4 2019 Feb 07, 2020	BUY	$9.97 - $20.28 $32,821 - $66,761	3,292 New	3,292 $60,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.